Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
UBS has revised up its 2026 forecasts for China’s trade, pointing to AI-related commerce as a dominant factor in stronger-than-expected performance in the first half of 2026. Exports rose 18% year-over-year and imports 26% in H1, with AI-linked trade accounting for nearly half of growth. UBS now expects 2026 nominal export growth of about 18% and i…
Baxter International rallied sharply in pre-market trading after delivering second-quarter 2026 results that outpaced analyst forecasts on both earnings and revenue, and after lifting its full-year adjusted EPS guidance. The company also shifted to a two-segment reporting model aimed at clearer visibility into core operations. The combination of th…
Vericel Corporation announced robust second quarter 2026 financial results with a 22% revenue increase to $77.5 million led by strong growth in MACI and Burn Care products. The company raised its full-year revenue guidance to $330-$340 million and authorized a $200 million share repurchase program, reflecting confidence in continued growth. Positiv…
Tenable shares plunged 15.0% in pre-market trading after the cybersecurity firm posted better-than-expected adjusted EPS and revenue for Q2 2026, but issued third-quarter revenue guidance below Street expectations and reported decelerating subscription growth. A notable analyst downgrade intensified the selloff, even as major U.S. indices moved hig…
Sonic Automotive fell 2.3% in pre-market trading after reporting Q2 2026 EPS of $1.82 on revenue of $3.9 billion, both edging past analyst expectations. The stock opened as low as $103.70 before recovering to $110.01, a move driven more by stretched valuations and profit-taking than by the quarterly numbers themselves. Market volatility tied to rec…
Microsoft reported strong Q4 results and an Azure growth rate that validates the Copilot strategy. Valuation is reasonable for a $2.9T behemoth with $73B in free cash flow, and technical momentum supports an entry near current levels. I'm upgrading to Buy with a medium risk rating, but investors should monitor ongoing capex and margin mix as the AI…
Porch Group shares jumped sharply in pre-market trading after the company posted second-quarter results that outperformed analyst expectations on revenue and earnings, raised 2026 guidance across key metrics, and disclosed a large stake held by BlackRock. Strong growth in the Insurance Services segment and a sizable rise in adjusted EBITDA helped f…
Altria Group reported second-quarter adjusted earnings per share of $1.48, narrowly below the LSEG consensus of $1.50, as weakness in premium cigarette and nicotine pouch demand weighed on results. Revenue net of excise taxes rose modestly to $5.36 billion, slightly ahead of expectations. The company pointed to higher fuel and everyday living costs…
Stantec, partnered with Johnson, Mirmiran and Thompson, secured a $150 million joint venture contract from the U.S. Army Corps of Engineers to design more than eight miles of integrated coastal storm risk management infrastructure on Charleston's peninsula. The project includes storm surge barriers, floodwalls, levees, pump stations, and nature-bas…
Las Vegas Sands Corp. shares fell in pre-market trading after Argus Research downgraded the stock from Buy to Hold. The downgrade compounds investor caution that has been building since LVS reported weaker-than-expected Q2 2026 results, with management pointing to unusually low hold rates in Macao as the primary driver of the shortfall.
Crescent Biopharma reported strong second-quarter 2026 results highlighting progress in multiple clinical trials for its novel cancer therapies, including CR-001, CR-002, and CR-003. The company completed a $143.7 million public offering, extending its cash runway into mid-2028, supporting ongoing development and upcoming clinical data readouts in …
Align Technology stock fell sharply in pre-market trading after the company issued third-quarter 2026 revenue guidance below analyst expectations alongside quarterly results. While quarterly revenue and adjusted earnings per share were broadly in line and clear aligner volume hit a record, weakness in Systems and Services, a £37.5 million (reported…
Block, Inc. director Anthony Mathew Eisen completed a series of share transactions that realized approximately $1.42 million in proceeds. The sales align with a broader wave of institutional upgrades, elevated equity valuations, and strategic product deployments designed to enhance merchant engagement and consumer retention.
ImmunityBio (NASDAQ:IBRX) saw its stock climb 7.5% on Thursday after the Emirates Drug Establishment granted marketing authorizations for ANKTIVA across two indications: BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) in combination with BCG, and metastatic non-small cell lung cancer (NSCLC) in combination with immune checkpoint inhibit…
The European Commission has unveiled plans to finance seven AI gigafactories across the European Union with a budget of €10 billion, up from an initial five, and aims to attract at least €20 billion in private investment. The facilities will integrate advanced AI processors, software, cloud infrastructure, high-speed connectivity and data centres, …
ACES (ALPS Clean Energy ETF) tracks U.S. and Canada-listed clean-energy names. Trading at $29.56 and sitting near its 52-week low, ACES shows an oversold technical profile (RSI ~28) while the clean-energy thematic continues to attract capital. This trade idea proposes a long position with entry at $29.50, stop at $27.00, and a $36.00 target over a …
Dragonfly Energy Holdings Corp., a leading US lithium battery technology company known for its Battle Born Batteries brand, will release its second quarter 2026 financial and operational results after market close on August 6, 2026. A conference call and live webcast will follow for investors and other interested parties. The company continues to f…
Leonardo DRS delivered robust Q2 2026 results with 10% revenue growth and a 59% increase in net earnings year-over-year. The company increased its 2026 adjusted EBITDA and adjusted diluted EPS guidance, supported by a record funded backlog of $5.1 billion. The $450 million acquisition of Raft enhances its AI, data fusion, and mission software capab…
SIGA Technologies, a commercial-stage pharmaceutical company specializing in infectious disease treatments, has scheduled a webcast and conference call for August 6, 2026, to discuss its second-quarter financial results and provide a business update. The call will be led by CEO Diem Nguyen and CFO Daniel Luckshire, and is accessible via webcast and…
Wave Life Sciences reported its Q2 2026 financial results, highlighting progress in its RNA-based drug pipeline including dosing initiation in Phase 2a obesity trial (WVE-007), a scheduled FDA meeting for accelerated approval pathway for its AATD therapy (WVE-006), and upcoming clinical trial application for its liver disease candidate (WVE-008). T…
Saia, Inc. announced its second quarter 2026 financial results, highlighting a 17.1% increase in revenue to $956.5 million, a 26.0% increase in operating income to $125.2 million, and diluted earnings per share of $3.51, up from $2.67 in Q2 2025. The company saw growth in LTL shipments and tonnage, maintained a low claims ratio, improved operating …
DT Midstream, Inc. announced strong financial results for Q2 2026 including a net income and operating earnings of $112 million, or $1.09 per diluted share. Adjusted EBITDA reached $305 million for the quarter. The company declared a $0.88 per share dividend and reaffirmed its 2026 Adjusted EBITDA guidance of $1.155 to $1.225 billion and 2027 outlo…
Laureate Education, Inc. announced robust financial results for Q2 2026, including 17% revenue growth to $615.9 million and a 40% increase in net income compared to Q2 2025. The company also reported a 10% increase in new enrollments and a 6% increase in total enrollments for the first half of 2026. Due to strong operating momentum and favorable cu…
FTI Consulting reported record second quarter 2026 revenues of $993.5 million, a 5.3% increase year-over-year driven by growth in Corporate Finance, Technology, and Forensic and Litigation Consulting segments. Despite higher revenues, net income decreased primarily due to increased costs, and GAAP EPS fell to $1.99 from $2.13 last year. Adjusted EP…
InflaRx N.V., a Nasdaq-listed biopharmaceutical company specializing in anti-inflammatory therapeutics targeting the complement system, will report its second quarter 2026 financial and operating results on August 6, 2026, before market open. The company focuses on developing treatments like izicopan and vilobelimab for inflammatory and renal disea…
